Carl Zeiss Meditec AG

Equities

AFX

DE0005313704

Advanced Medical Equipment & Technology

Market Closed - Xetra 11:39:44 2024-05-23 am EDT After market 03:58:01 pm
92.35 EUR -2.69% Intraday chart for Carl Zeiss Meditec AG 91.82 -0.57%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Goldman downgrades Carl Zeiss Meditec to 'Sell' - Target 90 euros DP
CARL ZEISS MEDITEC AG : Downgraded from Neutral to Sell by Goldman Sachs ZD
CARL ZEISS MEDITEC AG : Downgraded to Sell by Goldman Sachs ZD
Ailing hospitals slow down German medical technology sector DP
CARL ZEISS MEDITEC AG : JP Morgan reiterates its Sell rating ZD
CARL ZEISS MEDITEC AG : RBC gives a Buy rating ZD
CARL ZEISS MEDITEC AG : Receives a Buy rating from UBS ZD
CARL ZEISS MEDITEC AG : Hauck & Aufhauser gives a Buy rating ZD
CARL ZEISS MEDITEC AG : Deutsche Bank sticks Neutral ZD
CARL ZEISS MEDITEC AG : JP Morgan keeps a Sell rating ZD
CARL ZEISS MEDITEC : Weaker-than-expected Q2 + lacklustre guidance Alphavalue
CARL ZEISS MEDITEC AG : RBC remains its Buy rating ZD
CARL ZEISS MEDITEC AG : Berenberg remains Neutral ZD
CARL ZEISS MEDITEC AG : JP Morgan keeps a Sell rating ZD
CARL ZEISS MEDITEC AG : UBS maintains a Buy rating ZD
Jenoptik with jump in profits in first quarter - share price rises DP
U.S. Futures Mixed, European Stocks Rise DJ
Transcript : Carl Zeiss Meditec AG, H1 2024 Earnings Call, May 08, 2024
CARL ZEISS MEDITEC AG : Gets a Buy rating from UBS ZD
CARL ZEISS MEDITEC AG : Receives a Sell rating from JP Morgan ZD
CARL ZEISS MEDITEC : Potential remains intact, despite some near-term jitters Alphavalue
CARL ZEISS MEDITEC AG : Deutsche Bank sticks Neutral ZD
CARL ZEISS MEDITEC AG : Gets a Buy rating from DZ Bank ZD
CARL ZEISS MEDITEC AG : UBS maintains a Buy rating ZD
Goldman starts Carl Zeiss Meditec with 'Neutral' - Target 110 euros DP
Chart Carl Zeiss Meditec AG
More charts
Carl Zeiss Meditec AG is a Germany-based medical technology and device company. It offers offers complete solutions to diagnose and treat ophtalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The Company operates in two segments: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment comprises activities in the area of ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose and throat surgery, as well as the activities in the field of intraoperative radiation. The Company has various production sites in Europe, the United States and Asia.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
15
Last Close Price
94.9 EUR
Average target price
104.2 EUR
Spread / Average Target
+9.80%
Consensus
  1. Stock Market
  2. Equities
  3. AFX Stock
  4. News Carl Zeiss Meditec AG
  5. Carl Zeiss Meditec Board Approves EUR150 Million Share Buyback